Literature DB >> 32723604

Progesterone, reproduction, and psychiatric illness.

Lindsay R Standeven1, Katherine O McEvoy2, Lauren M Osborne3.   

Abstract

Mood and anxiety disorders are vastly overrepresented in women, and one important contributor to these differences is the fluctuation in sex steroids in women during the reproductive years. Considerable evidence supports a role for abnormal sensitivity to these hormonal fluctuations for some women, who develop mood symptoms associated with reproductive transitions. This chapter presents evidence of the role of endogenous progesterone and its metabolites in such mood symptoms, and then goes on to cover the evidence concerning exogenous progesterone's effects on mood. Overall, the literature does not support an association between exogenous progesterone and negative mood in the general population, but does indicate that subset of women may be vulnerable to such effects. Research is lacking on women with psychiatric illness.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Allopregnanolone; Anxiety; Contraception; Mood; Progesterone; Reproduction

Mesh:

Substances:

Year:  2020        PMID: 32723604      PMCID: PMC8011861          DOI: 10.1016/j.bpobgyn.2020.06.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  169 in total

1.  Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth.

Authors:  J C Abma; A Chandra; W D Mosher; L S Peterson; L J Piccinino
Journal:  Vital Health Stat 23       Date:  1997-05

2.  Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.

Authors:  B S Lee; B M Kang; B K Yoon; H Choi; H M Park; J G Kim
Journal:  Maturitas       Date:  2007-04-27       Impact factor: 4.342

Review 3.  GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.

Authors:  Torbjörn Bäckström; Marie Bixo; Jessica Strömberg
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

Review 4.  Premenstrual Dysphoric Disorder: Epidemiology and Treatment.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

5.  A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms.

Authors:  Thelma A Lovick; Vinicius G Guapo; Janete A Anselmo-Franci; Camila M Loureiro; Maria Clara M Faleiros; Cristina M Del Ben; Marcus L Brandão
Journal:  Psychoneuroendocrinology       Date:  2016-10-27       Impact factor: 4.905

6.  Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.

Authors:  Erika Timby; Torbjörn Bäckström; Sigrid Nyberg; Hans Stenlund; Anna-Carin N Wihlbäck; Marie Bixo
Journal:  Psychopharmacology (Berl)       Date:  2016-03-10       Impact factor: 4.530

7.  A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.

Authors:  Shruti Shambhavi; Rashmi Bagga; Pallavi Bansal; Jasvinder Kalra; Praveen Kumar
Journal:  J Obstet Gynaecol       Date:  2018-03-20       Impact factor: 1.246

8.  Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.

Authors:  Jacques E Rossouw; JoAnn E Manson; Andrew M Kaunitz; Garnet L Anderson
Journal:  Obstet Gynecol       Date:  2013-01       Impact factor: 7.661

9.  The effects of progesterone therapy in pregnancy: vaginal and intramuscular administration.

Authors:  Sedigheh Hantoushzadeh; Mahdi Sheikh; Mamak Shariat; Roodabeh Mansouri; Azin Ghamari; Fatemeh Golshahi
Journal:  J Matern Fetal Neonatal Med       Date:  2019-08-28

10.  A comparison of second and third generations combined oral contraceptive pills' effect on mood.

Authors:  Mahnaz Shahnazi; Azizeh Farshbaf Khalili; Fatemeh Ranjbar Kochaksaraei; Mohammad Asghari Jafarabadi; Kamal Gaza Banoi; Jila Nahaee; Somayeh Bayati Payan
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

View more
  2 in total

Review 1.  Possible Stress-Neuroendocrine System-Psychological Symptoms Relationship in Pregnant Women during the COVID-19 Pandemic.

Authors:  Giulia Gizzi; Claudia Mazzeschi; Elisa Delvecchio; Tommaso Beccari; Elisabetta Albi
Journal:  Int J Environ Res Public Health       Date:  2022-09-13       Impact factor: 4.614

2.  Electromagnetic Field (EMF) Radiation Alters Estrogen Release from the Pig Myometrium during the Peri-Implantation Period.

Authors:  Ewa Monika Drzewiecka; Wiktoria Kozlowska; Agata Zmijewska; Pawel Jozef Wydorski; Anita Franczak
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.